Found: 12
Select item for more details and to access through your institution.
Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy.
- Published in:
- BJU International, 2018, v. 122, n. 1, p. 89, doi. 10.1111/bju.14211
- By:
- Publication type:
- Article
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.
- Published in:
- BJU International, 2017, v. 119, n. 5, p. 684, doi. 10.1111/bju.13689
- By:
- Publication type:
- Article
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 6, p. 840, doi. 10.1002/cncr.33328
- By:
- Publication type:
- Article
Erdafitinib for locally advanced or metastatic urothelial carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 17, p. 2684, doi. 10.1002/cncr.28767
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1794, doi. 10.1002/cncr.28655
- By:
- Publication type:
- Article
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 540, doi. 10.1002/cncr.27751
- By:
- Publication type:
- Article
Incidence of Downstaging and Complete Remission After Neoadjuvant Chemotherapy for High-Risk Upper Tract Transitional Cell Carcinoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 13, p. 3127, doi. 10.1002/cncr.25050
- By:
- Publication type:
- Article
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 9, p. e2122998, doi. 10.1001/jamanetworkopen.2021.22998
- By:
- Publication type:
- Article
Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma.
- Published in:
- BJUI Compass, 2022, v. 3, n. 1, p. 37, doi. 10.1002/bco2.113
- By:
- Publication type:
- Article
Micropapillary Bladder Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 1, p. 62, doi. 10.1002/cncr.22756
- By:
- Publication type:
- Article